Principles of Treatments in Multiple Sclerosis

di Hawkins - Wolinsky • 2000 • dettagli prodotto

non più pubblicato

€ 70,79

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

DESCRIZIONE

With the growing concern for effective management of the acute and chronic symptoms of MS, and the development of new therapeutic options, this major review is a timely and valuable publication for all those caring for the patient with MS. Table of Contents: Foreword (Ian McDonald); INTRODUCTION: Pathogenesis and clinical subtypes of multiple sclerosis (Clive Hawkins); ACUTE RELAPSES: Treatment of acute relapses (David Barnes); DISEASE MODIFYING DRUGS - RELAPSING DISEASE: Interferon beta-1b (Donald Paty); Interferon beta-1a (Lance Blumhardt); Glatiramer acetate (Jerry Wolinsky); Immunoglobulins (Franz Fazekas, Ralf Gold, Hans-Peter Hartung and Siegrid Strasser-Fuchs); Azathioprine (Jacqueline Palace); Mitoxantrone (Gilles Edan and Sean Morrissey); DISEASE MODIFYING DRUGS - PROGRESSIVE DISEASE: Treatments for progressive forms of MS (Mariko Kita and Donald Goodkin); DISEASE MODIFYING DRUGS - EMERGING THERAPIES: Emerging therapies (Charles Davie and David Miller); DISEASE MODIFYING DRUGS - OVERVIEW: Overview of treatment strategies for relapsing and progressive disease (Clive Hawkins and Jerry Wolinsky); SYMPTOMATIC MANAGEMENT: Management of spasticity - pharmacological agents (Michael Barnes); Management of spasticity - botulinum toxin (Anthony Ward); Symptomatic management: ataxia, tremor and fatigue (Carolyn Young); The cause and management of bladder, sexual and bowel symptoms (Iqbal Hussain Clare Fowler); Neurobehavioural abnormalities (Anthony Feinstein); Multidisciplinary approach (Alan Thompson); DRUG SYNONYMS.